RSWM
CTMX icon

Robertson Stephens Wealth Management’s CytomX Therapeutics CTMX Stock Holding History

Robertson Stephens Wealth Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
+96,000
New +$367K 0.01% 491

Other funds holding CTMX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AGP
Aspire Growth Partners Miromar Lakes, Florida $172M AUM 33.61% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CPC
Congress Park Capital Saratoga Springs, New York $370M AUM 26.01% 1-Year Est. Return

Robertson Stephens Wealth Management's CTMX Position: Q2 2026 in Review

Robertson Stephens Wealth Management opened a new position in CytomX Therapeutics (CTMX) in Q2 2026: 96,000 shares worth $360K. The stake represents 0.01% of the portfolio and ranks #491 among its holdings.

23 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Robertson Stephens Wealth Management held 96,000 shares of CytomX Therapeutics worth $360K as of Q2 2026.
  • CytomX Therapeutics was a new Robertson Stephens Wealth Management position in Q2 2026.
  • CytomX Therapeutics made up 0.01% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #491 holding.
  • 23 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.